Table 2. Antihypertensive and non-antihypertensive drugs in the study population.
| Antihypertensive drugs | (n = 298) | Non-antihypertensive drugs | (n = 298) |
| Monotherapy, % | 66 | Lipid-lowering drugs, % | 0.3 |
| Diuretic, % | 43 | Uric acid-lowering drugs, % | 0 |
| CCB, % | 11 | Antiplatelet drugs, % | 6 |
| ACEI, % | 11 | NSAIDs, % | 9 |
| CAA, % | 1 | Antidiabetic drugs, | 29 |
| Combined therapy, % | 34 | ||
| Diuretic + ACEI, % | 17 | ||
| Diuretic + CCB, % | 9 | ||
| ACEI + CCB, % | 4 | ||
| Others, % | 4 |
Data are expressed as relative frequency (in percent).
CCB, calcium channel blocker; ACEI, angiotensin converting enzyme inhibitor; CAA, central-acting agents; NSAID, non-steroidal anti-inflammatory drugs.